Johnson & Johnson plans to start clinical trial of single-dose vaccine in India

Johnson & Johnson’s study of the vaccine’s effectiveness in Indian population is key because only 3.5% of its over 40,000 participants in global trial, conducted in US, Brazil, South Africa and a few other countries, were Asians